Healthy Living Arizona: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Arizona.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on February 3, 2026

Feb. 3, 2026

Neomorph Announces First Patient Dosed in Phase 1/2 Trial Evaluating NEO-811 For the Treatment of Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

GlobeNewswire

Feb. 3, 2026

RESTEM Announces First Patient Dosed in the Phase 2/3 IIMPACT Study of Restem-L in Idiopathic Inflammatory Myopathy

GlobeNewswire

Feb. 3, 2026

Socrates Health Solutions Announces Advances in Proprietary Non-Invasive Glucose Monitoring Technology; Shareholders Include NFL Players Association and OneTeam Partners

GlobeNewswire

Feb. 3, 2026

Adam Ferrari Announces 2026 Health Science Scholarship to Support Students Dedicated to Caring for Patients with Physical Disabilities

GlobeNewswire

Feb. 3, 2026

New Study Identifies How Intensive Care Units Prevent Patient Harm Before It Occurs

GlobeNewswire

Feb. 3, 2026

Allsup Helps Workers Navigate Medicare Options Amid Rising Health Plan Costs

GlobeNewswire

Feb. 3, 2026

Cynet Named a Strong Performer in 2026 Gartner Peer Insights™ “Voice of the Customer” for Endpoint Protection Platforms

GlobeNewswire

Feb. 3, 2026

Carrington College and San Joaquin Valley College in Visalia to Host Complimentary Oral Health Screening and Sealant Clinic

GlobeNewswire

Feb. 3, 2026

Mapi Pharma to Present New Safety and Efficacy Data from Glatiramer Acetate Depot Long-Acting Injection Phase II Study in Patients with Primary Progressive Multiple Sclerosis (PPMS) at ACTRIMS Forum 2026

GlobeNewswire

Feb. 3, 2026

AdhereHealth Announces Appointment of CEO Kempton Presley and President & COO Patrick McNulty as Members of the Board of Directors

GlobeNewswire

Feb. 3, 2026

HFMA’s Vitalic Health to gather more than 50 payers, providers and tech leaders to address rising claim denials

GlobeNewswire

Feb. 3, 2026

Department of Education Proposal Still Excludes Nursing from “Professional Degree” Definition

GlobeNewswire

Feb. 3, 2026

Inspira Technologies Validates Next-Gen Standalone HYLA™ Blood Sensor with Clinical-Grade Accuracy, Targeting $48 Billion Heart-Lung Surgery Market

GlobeNewswire

Feb. 3, 2026

Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products

GlobeNewswire

Feb. 3, 2026

SRx Health Solutions Significantly Reduces Short Position of Cryptocurrency Portfolio Amidst Current Market Volatility

GlobeNewswire

Feb. 3, 2026

Sangamo Therapeutics Announces Pricing of $25.0 Million Underwritten Offering

GlobeNewswire

Feb. 3, 2026

John Snow Labs Earns Pacific AI Governance Certification, Raising the Bar for Responsible AI in Healthcare

GlobeNewswire

Feb. 3, 2026

Eleusis to Debut as the World’s First Legal Luxury Psychedelic Immersion

GlobeNewswire

Feb. 3, 2026

Clever Care Health Plan Increases Enrollment by Nearly 50 Percent in 2026 Medicare Annual Enrollment Period

GlobeNewswire

Feb. 3, 2026

Mark Mikhael, CEO of Olympia and Wesley Pharmaceuticals, Appointed to the Florida Board of Pharmacy by Governor Ron DeSantis

GlobeNewswire